BIOMARKER TEST
Espacenet
Family 90458463
Abstract
The present invention relates to a method for the quantitative assessment of at least one biomarker for an infection, disease or disorder or at least one drug in a subject using a point-ofcare device , Wherein the detection occurs via upconverting nanoparticles. The invention also relates to the diagnosis and/or monitoring of the infection, disease or disorder or the treatment thereof in the subject. In addition, the present invention can be used to classify the stage of the infection, disease or disorder as well as to determine the effectiveness of a treatment regimen. Adjustments to biological drug treatment regimens can also be made by using the method according to the invention. A device that can be used for the present invention is also described.
Inventors 2
- Annemieke, Geluk
- Paul, Leo Albert Maria Corstjens
Inventors are linked to an Aachen author when surname and first name match exactly one author.
Applicants
- ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC) GBS Leiden
Cited papers 2 in the database
Non-patent literature as cited (19)
- - SINGLETONSAINSBURY: "Dictionary of Microbiology and Molecular Biology", 1994, JOHN WILEY AND SONS
- - HALEMARHAM: "The Harper Collins Dictionary of Biology", 1991, HARPER PERENNIAL
- - HOOIJ ET AL.: "Prototype multi-biomarker test for point-of-care leprosy diagnostics,", ISCIENCE, vol. 24, 2021, pages 102006
- - SWEENEY TEBRAVIAK LTATO CMKHATRI P.: "Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis", LANCET RESPIR MED., vol. 4, 2016, pages 213 - 24, XP055578985, DOI: 10.1016/S2213-2600(16)00048-5
- - WARSINSKE HC, RAO AM, MOREIRA FMF, SANTOS PCP, LIU AB, SCOTT M, MALHERBE ST, RONACHER K, WALZL G, WINTER J, SWEENEY TE, CRODA J, A: "Assessment of Validity of a Blood-Based 3-Gene Signature Score for Progression and Diagnosis of Tuberculosis, Disease Severity, and Treatment Response.", JAMA NETW OPEN, vol. 1, 2018, pages e183779, XP055579029, DOI: 10.1001/jamanetworkopen.2018.3779
- - SUTHERLAND JSVAN DER SPUY GGINDEH ATHUONG NTTNAMUGANGA AOWOLABI OMAYANJA-KIZZA HNSEREKO MTHWAITES GWINTER J: "TrENDx-TB Consortium. Diagnostic Accuracy of the Cepheid 3-gene Host Response Fingerstick Blood Test in a Prospective, Multi-site Study: Interim Results.", CLIN INFECT DIS., vol. 74, no. 12, 6 July 2022 (2022-07-06), pages 2136 - 2141
- - GUPTA-WRIGHT AHA HABDULGADAR SCROWDER RREMMANUEL JMUKWATAMUNDU JMARCELO DPHILLIPS PPJCHRISTOPHER DJNGUYEN NV, EVALUATION OF THE XPERT MTB HOST RESPONSE ASSAY FOR THE TRIAGE OF PATIENTS WITH PRESUMED PULMONARY TUBERCULOSIS: A MULTI-SITE PROSPECTIVE DIAGNOSTIC ACCURACY STUDY., Retrieved from the Internet <URL:http://dx.doi.org/10.2139/ssrn.4512925>
- - OLBRICH L*VERGHESE VP*FRANCKLING-SMITH ZSABI INTINGINYA NEMFINANGA ABANZE DVIEGAS SKHOSA CSEMPHERE R: "on behalf of the RaPaed-TB consortium. Diagnostic accuracy of a three-gene Mycobacterium tuberculosis host response cartridge using fingerstick blood for childhood tuberculosis: a multi-centre prospective study in low-income and middle-income countries.", LANCET INFECT DIS. PUBLISHED ONLINE, 30 October 2023 (2023-10-30)
- - VAN HOOIJ ATJON KON FAT EMDE JONG DKHATUN MSOREN SCHOWDHURY ASCHANDRA ROY JALAM KKIM JPRICHARDUS JH: "Corstjens PLAM. Prototype multi-biomarker test for point-of-care leprosy diagnostics.", ISCIENCE, vol. 24, no. 1, 2020, pages 102006
- - CHEGOU NNSUTHERLAND JSMALHERBE SCRAMPIN ACCORSTJENS PLGELUK AMAYANJA-KIZZA HLOXTON AGVAN DER SPUY GSTANLEY K: "AE-TBC consortium. Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB.", THORAX., vol. 71, no. 9, September 2016 (2016-09-01), pages 785 - 94
- - PIERNEEF LVAN HOOIJ ADE JONG DTJON KON FAT EMVAN MEIJGAARDEN KEPETRUCCIOLI EVANINI VROUKENS AHEGOLETTI DCORSTJENS PLAM: "BEAT-COVID study group. Host biomarker-based quantitative rapid tests for detection and treatment monitoring of tuberculosis and COVID-19.", ISCIENCE., vol. 26, no. 1, 20 January 2023 (2023-01-20), pages 105873
- - SCI REP., vol. 10, 2020, pages 8629
- - PIERNEEF, L. ET AL.: "Field-friendly anti-PGL-I serosurvey in children to monitor Mycobacterium leprae transmission in Bihar, India", FRONTIERS IN MEDICINE, vol. 10, 2023, pages 1260375
- - ORTUNO-GUTIERREZ ET AL., BMC INFECT. DIS, vol. 19, 2019, pages 1033
- - GUO JIUCHUAN ET AL: "A sensitive and quantitative prognosis of C-reactive protein at picogram level using mesoporous silica encapsulated core-shell up-conversion nanoparticle based lateral flow strip assay", TALANTA, vol. 230, 2021, XP086555409
- - TALHA S M ET AL: "UP-converting nanoparticles-based lateral flow assay for the detection of antibodies to HIV1 and 2", CLINICA CHIMICA ACTA, vol. 493, no. S1, W472, 2019, pages S668 - S669, XP085689095
- - WU SHIJIA ET AL: "A test strip for ochratoxin A based on the use of aptamer-modified fluorescence upconversion nanoparticles", MICROCHIMICA ACTA, vol. 185, no. 11, 2018, pages 1 - 8, XP036608250
- - ZHAN NAN ET AL: "Dual Detection of Procalcitonin and C-reactive Protein with an Up-converting Nanoparticle Based Lateral Flow Assay", ANALYTICAL SCIENCES, vol. 35, no. 3, 2019, pages 257 - 263, XP093197965
- - GUO JIUCHUAN ET AL: "An up Conversion Optical System Based on Mesoporous Silica Encapsulated Up-Converting Nanoparticles Labeled Lateral Flow Immunoassay for Procalcitonin Quantification in Plasma", IEEE JOURNAL OF SELECTED TOPICS IN QUANTUM ELECTRONICS, vol. 27, no. 5, 2021, pages 1 - 7, XP011842067